Using miniature human intestines grown in the lab, tuft cells have been found to act as regenerative stem cells in the human ...

The AVATAR Foundry is designed to allow AmplifyBio to help clients maximize the potency and tumor-killing activity of their ...

By leveraging AI, drug developers are moving beyond incremental gains in efficiency and engaging previously undruggable ...

Epigenetic, bioelectromic, synaptic, and senolytic interventions could rejuvenate cells and counter the effects of aging.

Aptadir engineers RNA therapies that inhibit DNMT-1 to prevent methylation in genes associated with myelodysplastic syndrome and other disorders.

The acquisition of the Vacaville facility significantly extends Lonza’s capacity for mammalian manufacturing in the U.S.

Whereas Biopharma 4.0 prioritizes productivity, Biopharma 5.0 emphasizes environmental and social sustainability.

Research by a Stanford University team of scientists has shed new light on how and why neural stem cells (NSCs), the cells ...

KBI Biopharma says they’re selecting the best technologies to fill gaps in their processes with grassroots help from their ...

Industry, academic institutions, suppliers, and regulatory agencies working together can yield state-of-the-art downstream ...

Quell’s proprietary platform has been developed to generate engineered CAR-Treg cell therapies that can be directed to ...

Tests in mice suggest glucagon micelle could be used as a responsive system to prevent the onset of insulin-induced deep ...